Compound 1409
Identifiers
- Canonical SMILES:
OCCCNC(=O)c1cc(Cl)c(O)c(c1)S(=O)(=O)N(Cc1ccc(F)cc1)Cc1cccc(c1)-c1ccc(Cl)cc1
- InChi:
InChI=1S/C30H27Cl2FN2O5S/c31-25-9-7-22(8-10-25)23-4-1-3-21(15-23)19-35(18-20-5-11-26(33)12-6-20)41(39,40)28-17-24(16-27(32)29(28)37)30(38)34-13-2-14-36/h1,3-12,15-17,36-37H,2,13-14,18-19H2,(H,34,38)
- InChiKey:
XFCKBGXIOAWEFT-UHFFFAOYSA-N
External links
![]() 66616638 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Publication | Name |
---|---|
Kyoung S. Kim, Robert M. Borzilleri, Zhen-Wei Cai, Kap-Sun Yeung, Bristol-Myers Squibb Company. . Hydroxyphenylsulfonamides as antiapoptotic bcl inhibitors None. | 213 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 5.91 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 616.10 g/mol | |||
HBA | 7 | |||
HBD | 3 | |||
HBA + HBD | 10 | |||
AlogP | 5.61 | |||
TPSA | 106.94 | |||
RB | 10 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2009152082 | 213 | BCL2 P10415 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 5.91 | |
WO2009152082 | 213 | MCL1 Q07820 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 5.57 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5765 | 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid | DB03124 | |
0.4821 | Clorexolone | DB13617 | |
0.4759 | N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide | DB07115 | |
0.4688 | ABT-639 | DB15055 | |
0.4472 | 2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid | DB07691 | |
0.4451 | Xipamide | DB13803 | |
0.4381 | Avagacestat | DB11893 | |
0.4316 | Quinethazone | DB01325 | |
0.4315 | 4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide | DB02429 | |
0.4271 | Glyburide | DB01016 | |
0.4269 | Clopamide | DB13792 | |
0.4260 | N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINE | DB07963 | |
0.4255 | 2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE | DB08000 | |
0.4238 | Sulfabenzamide | DB09355 | |
0.4237 | Sulpiride | DB00391 |